Company / CapEx per Share
Seres Therapeutics, Inc. CapEx per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.92
FY2025
5-year range
$0.01 / $0.92
FY2021-FY2025
Trend
+1106.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +1107% YoY in FY2025, a notable deviation from the 9-year average annual change of +295%.
Based on SEC 10-K filings.
0.92 in FY2025 with a 10-year CAGR of +43.3%.
Improved from $0.01 to $0.92 over the past 3 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +423.4%
- 5-Year CAGR
- +101.7%
- 10-Year CAGR
- +43.3%
Key checks
Key Insights
- In FY2025, capex per share increased 1106.9% year-over-year.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.92 | +1106.9% |
| FY2023 | $0.08 | +1087.8% |
| FY2022 | $0.01 | -41.3% |
| FY2021 | $0.01 | -60.3% |
| FY2020 | $0.03 | -75.8% |
| FY2019 | $0.11 | -78.4% |
| FY2018 | $0.53 | +390.1% |
| FY2017 | $0.11 | +322.0% |
| FY2016 | $0.03 | +1.4% |
| FY2015 | $0.03 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026